Not applicableStudy completedNCT02770482What this trial is testingAmyloid Beta-peptide 1-40 and Alzheimer's DiseaseWho this might be right forAlzheimer Disease CHU de Reims 204
Early research (Phase 1)Ended earlyNCT00605059What this trial is testingEvaluation of [123I] AV94 and SPECT in Subjects With Alzheimer Disease in Comparison to Healthy SubjectsWho this might be right forAlzheimer Disease Institute for Neurodegenerative Disorders 3
Not applicableStudy completedNCT02129452What this trial is testingOlfactory Neuroepithelial Tissue of Alzheimer DiseaseWho this might be right forAlzheimer Disease Seoul National University Hospital 40
Not applicableStudy completedNCT07294586What this trial is testingExploratory Clinical Study and Validation of Blood Biomarkers for Alzheimer's DiseaseWho this might be right forAlzheimer DiseaseDementiaNeurodegenerative Disorders+5 more Amoneta Diagnostics SAS 200
Early research (Phase 1)Study completedNCT02033668What this trial is testingPharmacokinetic (PK) Study of GSK933776 in Healthy VolunteersWho this might be right forAtrophy, Geographic GlaxoSmithKline 36
Testing effectiveness (Phase 2)Looking for participantsNCT05774704What this trial is testingCurcumin and Retinal StudyWho this might be right forBioavailabilityGut MicrobiomeSafety Texas Tech University Health Sciences Center 60
Early research (Phase 1)Ended earlyNCT00870519What this trial is testingBrain Imaging Study in Subjects With Alzheimer Disease in Comparison to Healthy SubjectsWho this might be right forAlzheimer's Disease Institute for Neurodegenerative Disorders 2
Not applicableStudy completedNCT07307872What this trial is testingA Biomarker-chip Assay in Preserved Red Blood Cells for the Diagnosis of Alzheimer's DiseaseWho this might be right forAlzheimer's Disease (AD)Neurodegenerative DiseaseDementia+1 more Amoneta Diagnostics SAS 150
Very early researchStudy completedNCT01217021What this trial is testingSafety and Efficacy of Positron Emission Tomography (PET) Imaging With MNI-558Who this might be right forAlzheimer Disease Institute for Neurodegenerative Disorders 10
Not applicableStudy completedNCT02063217What this trial is testingModulation of CSF Amyloid-beta Concentrations Via Behavioral Sleep Deprivation and Pharmacological Sleep InductionWho this might be right forAmyloid-beta Washington University School of Medicine 36
Testing effectiveness (Phase 2)Study completedNCT03354143What this trial is testingHypertension, Intracranial Pulsatility and Brain Amyloid-beta Accumulation in Older Adults (HIPAC Trial)Who this might be right forHypertension University of Texas Southwestern Medical Center 85
Not applicableStudy completedNCT02021682What this trial is testingCNS and Plasma Amyloid-Beta Kinetics in Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Washington University School of Medicine 58
Not applicableUnknownNCT01819545What this trial is testingThe Study of microRNA 107 (miRNA 107) and Beta-amyloid Precursor Protein-cleaving Enzyme 1 (BACE1) Messenger Ribonucleic Acid (mRNA) Gene Expression in Cerebrospinal Fluid and Peripheral Blood of Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Shanghai Mental Health Center 300
Post-approval studies (Phase 4)Not Yet RecruitingNCT06911944What this trial is testingAmyloid Lowering for Alzheimer's in Down's With Donanemab InvestigationWho this might be right forDown Syndrome (DS)Down Syndrome (Trisomy 21)Alzheimer Disease+1 more Michael Rafii, MD, PhD 60
Large-scale testing (Phase 3)Study completedNCT01020838What this trial is testingPhase III Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid Compared to HistopathologyWho this might be right forAlzheimer Disease Life Molecular Imaging SA 218
Not applicableActive Not RecruitingNCT05820932What this trial is testingPredicting Cognitive Decline From Androgen Deprivation TherapyWho this might be right forProstate Cancer University of California, San Francisco 32
Early research (Phase 1)Study completedNCT00556660What this trial is testingEvaluation of [123I] AV51 and SPECT as a Marker of Beta-amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy SubjectsWho this might be right forAlzheimer Disease Institute for Neurodegenerative Disorders 20
Very early researchEnded earlyNCT01000870What this trial is testingSafety and Efficacy of Positron Emission Tomography Imaging With MNI-513Who this might be right forAlzheimer Disease Institute for Neurodegenerative Disorders 6
Early research (Phase 1)Study completedNCT01424436What this trial is testingModulation of Abeta Levels by GSK933776 in Alzheimer's Disease PatientWho this might be right forAlzheimer's Disease GlaxoSmithKline 19
Post-approval studies (Phase 4)Study completedNCT02161458What this trial is testingEscitalopram Effects on CSF Amyloid BetaWho this might be right forAmyloid Beta Protein University of Pennsylvania 98